XBiotech (XBIT) Market Capitalization (2015 - 2026)

XBiotech has reported Market Capitalization for 12 years, with the latest figure at $70.1 million in Q2 2026.

• On a quarterly basis, Market Capitalization fell 22.56% year-over-year to $70.1 million in Q2 2026; TTM through Jun 2026 was $70.1 million, a 22.56% decrease from a year earlier, with the FY2025 full-year figure at $72.9 million, down 39.49% from the prior year.
• Market Capitalization was $70.1 million for Q2 2026 at XBiotech, down from $72.9 million in the prior quarter.
• The five-year high for Market Capitalization was $263.0 million in Q1 2022, with the low at $70.1 million in Q2 2026.
• Average Market Capitalization over 5 years is $138.7 million, with a median of $120.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization tumbled 72.01% in 2022, then soared 135.74% in 2024.
• Over 5 years, Market Capitalization stood at $106.8 million in 2022, then grew by 13.95% to $121.7 million in 2023, then dropped by 1.09% to $120.4 million in 2024, then slumped by 39.49% to $72.9 million in 2025, then decreased by 3.77% to $70.1 million in 2026.
• The last three Market Capitalization figures came in at $70.1 million (Q2 2026), $72.9 million (Q4 2025), and $81.1 million (Q3 2025), per Business Quant data.